OOIR: Observatory of International Research

Papers

(The median citation count of Cellular & Molecular Biology Letters is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Correction: Laboratory methods to decipher epigenetic signatures: a comparative review	132
Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC	130
Targeting microRNAs with thymoquinone: a new approach for cancer therapy	127
Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development	117
Targeting UBR5 in hepatocellular carcinoma cells and precise treatment via echinacoside nanodelivery	109
Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment	106
Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway	103
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges	101
Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects	93
Slc25a5 regulates adipogenesis by modulating ERK signaling in OP9 cells	90
ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1	85
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review	84
Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis	81
Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis	77
Osteoporosis pathogenesis and treatment: existing and emerging avenues	70
Mitochondrial potassium channels: A novel calcitriol target	68
lncRNA PVT1: a novel oncogene in multiple cancers	64
Integrated analysis of tRNA-derived small RNAs in proliferative human aortic smooth muscle cells	62
The interaction of canonical Wnt/β-catenin signaling with protein lysine acetylation	57
Melatonin and cancer suppression: insights into its effects on DNA methylation	56
5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo	54
tRF-3013b inhibits gallbladder cancer proliferation by targeting TPRG1L	50
COVID-19 therapies: do we see substantial progress?	48
Reversely immortalized mouse salivary gland cells presented a promising metabolic and fibrotic response upon BMP9/Gdf2 stimulation	47
Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress	47

Targeting uridine–cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma	46
Esterase D stabilizes FKBP25 to suppress mTORC1	46
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner	45
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration	45
Diversification of PAR signaling through receptor crosstalk	44
Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma	44
SNHG3 could promote prostate cancer progression through reducing methionine dependence of PCa cells	43
Absent in melanoma 2 (AIM2) in rheumatoid arthritis: novel molecular insights and implications	42
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway	41
RNF7 inhibits apoptosis and sunitinib sensitivity and promotes glycolysis in renal cell carcinoma via the SOCS1/JAK/STAT3 feedback loop	40
MicroRNA let-7 and viral infections: focus on mechanisms of action	34
Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro	33
Construction and investigation of β3GNT2-associated regulatory network in esophageal carcinoma	33
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies	32
The lncRNA DANCR promotes development of atherosclerosis by regulating the miR-214-5p/COX20 signaling pathway	32
Artemisinin relieves osteoarthritis by activating mitochondrial autophagy through reducing TNFSF11 expression and inhibiting PI3K/AKT/mTOR signaling in cartilage	31
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization	31
Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells	30
LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability	29
RETRACTED ARTICLE:Parecoxib inhibits esophageal squamous cell carcinoma progression via the PDK1–AKT pathway	29
The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability	27
MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30	27
The role of macrophage subtypes and exosomes in immunomodulation	26
The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer	26
Laboratory methods to decipher epigenetic signatures: a comparative review	26
Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?	26
LncRNA HCG18 promotes osteosarcoma growth by enhanced aerobic glycolysis via the miR-365a-3p/PGK1 axis	25
CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer	25
Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid	25
Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages	24
Correction to: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells	24
Metabolic disorders sensitise endometrial carcinoma through endoplasmic reticulum stress	24
Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting	24
TBHQ attenuates ferroptosis against 5-fluorouracil-induced intestinal epithelial cell injury and intestinal mucositis via activation of Nrf2	23
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review	23
Obacunone alleviates ferroptosis during lipopolysaccharide-induced acute lung injury by upregulating Nrf2-dependent antioxidant responses	23
A rare mutation (p.F149del) of the NT5C3A gene is associated with pyrimidine 5′-nucleotidase deficiency	22
Specificity of H2O2 signaling in leaf senescence: is the ratio of H2O2 contents in different cellular compartments sensed in Arabidopsis plants?	22
MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer	21
Direct differentiation of tonsillar biopsy-derived stem cells to the neuronal lineage	21
Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62–Keap1–NRF2 pathway	21
Protective effects of dexmedetomidine in vital organ injury: crucial roles of autophagy	21
The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors	21